RESTRICTED STOCK AWARD AGREEMENT ALLIQUA, INC.Restricted Stock Award Agreement • March 24th, 2014 • Alliqua, Inc. • Surgical & medical instruments & apparatus
RESTRICTED STOCK AWARD AGREEMENT ALLIQUA, INC.Restricted Stock Award Agreement • March 24th, 2014 • Alliqua, Inc. • Surgical & medical instruments & apparatus
SUPPLY AGREEMENT BY AND BETWEENSupply Agreement • March 24th, 2014 • Alliqua, Inc. • Surgical & medical instruments & apparatus • New York
THIS SUPPLY AGREEMENT (this “Agreement”) dated as of November 14, 2013 (the “Effective Date”), by and between Anthrogenesis Corporation, a Delaware corporation doing business as Celgene Cellular Therapeutics (“CCT”), and Alliqua, Inc., a Florida corporation (“Alliqua”). Alliqua and CCT may each be referred to as a “Party” or collectively be referred to as the “Parties”.
ALLIQUA, INC.Warrant Agreement • March 24th, 2014 • Alliqua, Inc. • Surgical & medical instruments & apparatus • New York
Alliqua, Inc., a Florida corporation (the “Company”), hereby certifies that, for value received, Celgene Corporation, a Delaware corporation or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of 36,585,366 shares of common stock, $0.001 par value per share (the “Common Stock”) of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $0.13 per share (as adjusted from time to time as provided in Section 8, the “Exercise Price”), at any time and on or after November 18, 2013 (the “Initial Exercise Date”) and through and including the date that is five (5) years from the Initial Exercise Date, or if such day is not a Business Day (as defined in the Purchase Agreement, as defined below), on the next preceding Business Day (the “Expiration Date”), and subject to the following terms and conditions. This Warrant (this “Warrant”) is issued pursuant to that certain Stock Purchase Agre
ALLIQUA, INC. Securities Purchase AgreementSecurities Purchase Agreement • March 24th, 2014 • Alliqua, Inc. • Surgical & medical instruments & apparatus • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 18, 2013, by and among Alliqua, Inc., a Florida corporation (the “Company”), and each of the investors identified on the signature pages hereto (each, an “Investor” and together, the “Investors”).
STOCK PURCHASE AGREEMENT BY AND BETWEENStock Purchase Agreement • March 24th, 2014 • Alliqua, Inc. • Surgical & medical instruments & apparatus • New York
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of November 14, 2013, by and between Alliqua, Inc., a Florida corporation (the “Company”), and Celgene Corporation, a Delaware corporation (“Investor”).
LICENSE, MARKETING AND DEVELOPMENT AGREEMENT BY AND BETWEEN ANTHROGENESIS CORPORATION, D/B/A CCT AND ALLIQUA, INC. NOVEMBER 14, 2013License, Marketing and Development Agreement • March 24th, 2014 • Alliqua, Inc. • Surgical & medical instruments & apparatus • New York
This License, MARKETING AND DEVELOPMENT Agreement (the “Agreement”) is entered into as of November 14, 2013 (the “Effective Date”) by and between Anthrogenesis Corporation, d/b/a CELGENE CELLULAR THERAPEUTICS (“CCT”), a New Jersey corporation having a principal place of business at 33 Technology Drive, 2nd Floor, Warren, NJ 07059 (“CCT”), and Alliqua, INC., a Florida corporation having a principal place of business at 2150 Cabot Boulevard West, Langhorne, Pennsylvania (“Alliqua”). Alliqua and CCT may each be referred to as a “Party” or collectively be referred to as the “Parties”.
